King M J, Sale G J
Department of Biochemistry, School of Biochemical and Physiological Sciences, University of Southampton, U.K.
Biochem J. 1988 Dec 15;256(3):893-902. doi: 10.1042/bj2560893.
Calmodulin-dependent protein phosphatase has been proposed to be an important phosphotyrosyl-protein phosphatase. The ability of the enzyme to attack autophosphorylated insulin receptor was examined and compared with the known ability of the enzyme to act on autophosphorylated epidermal-growth-factor (EGF) receptor. Purified calmodulin-dependent protein phosphatase was shown to catalyse the complete dephosphorylation of phosphotyrosyl-(insulin receptor). When compared at similar concentrations, 32P-labelled EGF receptor was dephosphorylated at greater than 3 times the rate of 32P-labelled insulin receptor; both dephosphorylations exhibited similar dependence on metal ions and calmodulin. Native phosphotyrosyl-protein phosphatases in cell extracts were also characterized. With rat liver, heart or brain, most (75%) of the native phosphatase activity against both 32P-labelled insulin and EGF receptors was recovered in the particulate fraction of the cell, with only 25% in the soluble fraction. This subcellular distribution contrasts with results of previous studies using artificial substrates, which found most of the phosphotyrosyl-protein phosphatase activity in the soluble fraction of the cell. Properties of particulate and soluble phosphatase activity against 32P-labelled insulin and EGF receptors are reported. The contribution of calmodulin-dependent protein phosphatase activity to phosphotyrosyl-protein phosphatase activity in cell fractions was determined by utilizing the unique metal-ion dependence of calmodulin-dependent protein phosphatase. Whereas Ni2+ (1 mM) markedly activated the calmodulin-dependent protein phosphatase, it was found to inhibit potently both particulate and soluble phosphotyrosyl-protein phosphatase activity. In fractions from rat liver, brain and heart, total phosphotyrosyl-protein phosphatase activity against both 32P-labelled receptors was inhibited by 99.5 +/- 6% (mean +/- S.E.M., 30 observations) by Ni2+. Results of Ni2+ inhibition studies were confirmed by other methods. It is concluded that in cell extracts phosphotyrosyl-protein phosphatases other than calmodulin-dependent protein phosphatase are the major phosphotyrosyl-(insulin receptor) and -(EGF receptor) phosphatases.
钙调蛋白依赖性蛋白磷酸酶被认为是一种重要的磷酸酪氨酸蛋白磷酸酶。研究了该酶作用于自身磷酸化胰岛素受体的能力,并与已知的该酶作用于自身磷酸化表皮生长因子(EGF)受体的能力进行了比较。结果表明,纯化的钙调蛋白依赖性蛋白磷酸酶可催化磷酸酪氨酸-(胰岛素受体)的完全去磷酸化。在相似浓度下比较时,32P标记的EGF受体去磷酸化的速率比32P标记的胰岛素受体快3倍以上;两种去磷酸化反应对金属离子和钙调蛋白的依赖性相似。还对细胞提取物中的天然磷酸酪氨酸蛋白磷酸酶进行了表征。对于大鼠肝脏、心脏或大脑,针对32P标记的胰岛素和EGF受体的大部分(75%)天然磷酸酶活性存在于细胞的颗粒部分,只有25%存在于可溶部分。这种亚细胞分布与先前使用人工底物的研究结果形成对比,后者发现大部分磷酸酪氨酸蛋白磷酸酶活性存在于细胞的可溶部分。报道了颗粒和可溶部分针对32P标记的胰岛素和EGF受体的磷酸酶活性特性。利用钙调蛋白依赖性蛋白磷酸酶独特的金属离子依赖性,确定了钙调蛋白依赖性蛋白磷酸酶活性对细胞部分中磷酸酪氨酸蛋白磷酸酶活性的贡献。虽然Ni2+(1 mM)可显著激活钙调蛋白依赖性蛋白磷酸酶,但发现它能强烈抑制颗粒和可溶部分的磷酸酪氨酸蛋白磷酸酶活性。在大鼠肝脏、大脑和心脏的部分中,Ni2+可使针对两种32P标记受体的总磷酸酪氨酸蛋白磷酸酶活性受到99.5±6%(平均值±标准误,30次观察)的抑制。Ni2+抑制研究的结果通过其他方法得到了证实。结论是,在细胞提取物中,除钙调蛋白依赖性蛋白磷酸酶外的其他磷酸酪氨酸蛋白磷酸酶是主要的磷酸酪氨酸-(胰岛素受体)和-(EGF受体)磷酸酶。